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Abstract 
 
Aristolochic acid (AA) has, in the last decade, become widely promoted as the cause of the 
Balkan endemic nephropathy and associated renal or urothelial tumours, although without 
substantial focal evidence of the quantitative dietary exposure via bread in specific 
households in hyperendemic villages. Occasional ethnobotanical use of Aristolochia clematitis 
might be a source of AA, and Pliocene lignite contamination of well-water is also a putative 
health risk factor. The aim of this study was two-fold: to verify if extracts of A. clematitis and 
Pliocene, or AA by itself, could induce the development of renal or urothelial tumours, and to 
test the utility of the ribosomal protein p-S6 to identify preneoplastic transformation. Rats 
were given extracts of A. clematitis in drinking water or AA I, by gavage.  After seven months, 
renal morphology was studied using conventional haematoxylin and eosin and 
immunohistochemistry for ribosomal p-S6 protein.  Plant extracts (cumulative AA 
approximately 1.8 g/kg b.w.) were tolerated and caused no gross pathology or renal 
histopathological change, with only faint diffuse p-S6 protein (except in the papilla) as in 
controls. Cumulative AA I (150 mg/kg b.w. given over 3 days) was also tolerated for seven 
months by all recipients, without gross pathology or kidney tumours. However, p-S6 protein 
over-expression was consistent particularly within the renal papilla. In one case given AA I, 
intense p-S6 protein staining of a proximal tubule fragment crucially matched the pre-
neoplastic histology in an adjacent kidney section.  We briefly discuss these findings, which 
compound uncertainty concerning the cause of the renal or upper urinary tract tumours of 
the Balkan endemic nephropathy.  
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Introduction 
 
As both a nephrotoxic and a carcinogenic 
environmental toxin, aristolochic acid (AA),  
 
 
as a constituent of plants of the genus 
Aristolochia, has in recent years been 
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implicated as the major disease determinant 
for the Balkan Endemic Nephropathy (BEN). 
BEN was recognised in the 1950s as a 
distinct and idiopathic entity in certain rural 
communities of Bulgaria, Romania and 
Yugoslavia. Krogh (1) first suggested that 
the mycotoxin ochratoxin A (OTA), to which 
a nephropathy occurring in the Danish 
bacon industry had been ascribed in the 
1970s, might also cause the slow silent 
bilateral renal atrophy of the human BEN. 
The arable weed plant Aristolochia 
clematitis, which is endemic in parts of 
Eastern Europe  was  also suggested as a 
possible cause of BEN nearly half a century 
ago (2) . However, Aristolochia spp. have 
long formed part of the oriental materia 
medica in herbal formulations (3) and the 
general toxicity and carcinogenicity of the 
principal toxic component, AA, was already 
well established in experimental animals (4, 
5). Concurrently, other aetiological factors 
are being considered, since the natural 
occurrence of  Pliocene lignite deposits in 
the Balkans fits rather closely with the 
geographical distribution of BEN hotspots 
(6), thereby offering rather strong prima 
facie evidence for exposure to leachate from 
such deposits into the well-waters on which 
rural communities rely. However, no lignite 
component has yet been shown 
experimentally to mimic any of the BEN 
pathology.  
 
The putative role of AA in tumours of the 
renal pelvis and urethra gained attention in 
the 1990s during the local epidemic of 
nephropathy in Belgian women. This was 
attributed to formulation error in a Chinese 
herbal slimming medication involving 
accidental inclusion of Asian material in 
which AA was a characteristic toxic alkaloid.  
Early attempts to find an experimental 
animal model to mimic the development of 
renal or urothelial tumours used female 
rabbits (7). Intraperitoneal delivery of a 
mixture of AA  I and II (0.1 mg/kg b.w.) 5 
days a week to 12 animals for up to nearly 2 
years caused marked glucosuria and 
proteinuria and extensive renal tubular 
atrophy and interstitial fibrosis in a context 
of reduced feed intake and poor concomitant 
growth. One rabbit died, but three developed 
urinary tract tumours (one small in situ 
renal carcinoma, one tubulopapillary 
adenoma, and one transitional cell 
carcinoma in mid-ureter together with an 
extensive peritoneal papillary malignant 
mesothelioma.  Another report on rat 
tumourigenicity of AA, yielding kidney 
neoplasms in all experimental individuals 
six months after sub-acute insult per os 
while not arising from transitional cell 
epithelia, is that of Cui et al (8). If AA is an 
etiological agent for renal or urothelial 
tumours in BEN, identification of early 
markers of neoplastic transformation may 
aid in the diagnosis and management of AA-
induced renal/urothelial tumours. In this 
study, we tested the utility of the ribosomal 
protein p-S6 (phospho S6 ribosomal protein) 
as a potential marker for AA-induced renal 
tumours in rats treated with AA. Further, 
since our Balkan 1H NMR metabolomic 
study differentiated a BEN cohort in 
Romania from one in Bulgaria (9), and that 
we are aware of ethnobotanical exposure to 
AAs, we have included animals additionally 
given Pliocene lignite infusion and pilot 
groups given chronic exposure to 
ethnobotanical extracts of A. clematitis.  
 
Focus on expression of ribosomal p-S6 
protein in kidney of rats challenged with AA 
has arisen from our previous experience 
with cancers in kidneys of rats given chronic 
tolerable exposure to dietary OTA (10). That 
study revealed a consistent specificity for 
the renal tumours attributable to that 
environmental alkaloid in contrast to other 
neoplasms, e.g. testis tumours or 
subcutaneous fibrosarcoma, of other 
causation. The OTA findings were 
reminiscent of those in the spontaneous 
renal tumours of the Eker rat (11). The Eker 
strain is heterozygous for a dominantly-
inherited germline mutation in the Tsc 2 
tumour suppressor gene that is recognised 
as a valid model for human tuberous 
sclerosis complex (12), with two genes (TSC1 
and TSC 2) involved and tumours occurring 
sometimes in kidney. Activation of the TSC 
2 and folliculin genes in mice has been 
associated with both renal tumour 
development and mammalian target of 
rapamycin (mTOR) dysregulation (13). A few 
rare human cases of familial renal cell 
carcinoma have been attributed to 
disruption of the TSC 2 gene (14). More 
recently, Wilson et al (15) generated Tsc 1+/-
mice with predisposition to kidney cancer, 
and strong staining for p-S6 protein in those 
tumours. These observations form a 
rationale for novel pilot exploration of p-S6 
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Figure 1. Control (untreated) kidneys; A, haematoxylin and eosin staining showing normal histology 
(bar 2.5 mm); B, Negative immunohistochemical test for p-S6 in untreated kidney; C, diffuse weak 
staining for p-S6 in cortex but none in papilla; D, tangential section through renal cortex typical of 
treated rats illustrating diffuse staining for p-S6 (applicable also to untreated controls as in C), D (bar 
100 μm). 
 
 
as a marker for putative AA-induced 
renal/urothelial tumours or pre-neoplastic 
transformation. 
 
Materials and methods 
 
All animal experiments complied with the 
European Convention for the Protection of 
Vertebrate Animals used for Experimental 
and other Scientific Purposes (Strasbourg, 
France, 1986). The University of Medicine 
and Pharmacy Timisoara Ethical Committee 
approved the experimental protocols. Young 
female Sprague-Dawley rats were caged in a 
day-night controlled room, properly 
ventilated, and with ad libitum access to 
food and water. Animals were observed daily 
and growth was monitored by weight. 
Within available resources, several 
biochemical parameters were monitored at 
intervals to detect any marked changes. For 
assessment of liver and kidney function, 
aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), creatinine and urea 
were evaluated. Blood was collected from a 
femoral vein, allowed to clot for 30 min, 
Gruia et al.                                                                                         Pre-neoplastic kidney lesion from aristolochic acid 
 
Journal of Kidney Cancer and VHL 2015; 2(4):153-162.         http://jkcvhl.com  156 
 
centrifuged and processed for serum 
concentration according to Siemens 
Diagnostics ALT-AST kit, creatinine kit and 
urea kit, respectively. 
 
Experiment 1  
 
This experiment tested aqueous extracts of 
A. clematitis, using six rats (commencing 5 
weeks old; 82-137 g) for six months. A. 
clematitis plants had been collected from 
wild habitats (Western and South-western 
Romania, May-June, 2006) and left to dry in 
a controlled humidity room. Dried leaves 
were powdered with pestle and mortar. Two 
types of extract were prepared. For two rats, 
two grams of leaves were Soxhlet-extracted 
in 200 mL of distilled water for 30 min. For 
two other rats one gram of leaves was 
suspended in 200 mL of hot (80 ºC) distilled 
water and left to infuse for 30 min, in a 
manner reproducing the ethnobotanical 
decoction preparation of A. clematitis in 
some Romanian rural areas. Two more rats 
served as controls and were given tap water. 
 
A. clematitis leaf aqueous extracts were 
analyzed by an HPLC method to establish 
AA concentrations. An analytical standard 
containing a mixture of AA I and II was 
purchased from Sigma-Aldrich (St. Louis, 
CO, USA). Acetonitrile (HPLC-grade) and 
HPLC grade water were also obtained from 
Sigma-Aldrich. All experiments in this study 
were performed with an Agilent 1100 HPLC 
system. An HP 1100 liquid chromatograph 
system (Agilent Technologies, Santa Clara, 
CA, USA) consisting of a binary pump, a 
thermostat-controlled column and UV 
detector plus on-line degasser was used. 
Data were analyzed using the HP 
Chemstation System. The analytical column 
was a Zorbax SB-C18 (5 μm, 4.6 x 250 mm) 
(Agilent Technologies). The eluents 
consisted of HPLC grade water acidified with 
phosphoric acid 98 % to a pH value of 3 (A) 
and acetonitrile (B). The initial condition 
was set at 20 % B with a gradient to 70 % B 
in 25 min, then a linear gradient to 100 % B 
in 30 min. The flow rate was 0.5 mL/min. 
All analyses were monitored at 390 nm. The 
column temperature was set at 40 °C, and 
the sample injection volume was 20 μL. The 
peak of AA I and II in samples was identified 
by comparing their retention time values 
and UV spectra with those of the standard. 
The aqueous extracts obtained by Soxhlet 
and hot water infusion were analyzed prior 
to the beginning of the experiment and AA 
concentrations were determined. To 
calculate the concentration of AA, a 
calibration curve was made based on 
standard AA dilutions from 1 to 40 mg/100 
mL. AA standard dilutions were prepared in 
acetonitrile. On average, 2.96 mg AAI and 
II/100 mL was found in the Soxhlet aqueous 
extract of A. clematitis leaves, while the hot 
water infusion contained on average 2.5 
mg/100 mL. Predicted intake volume was 
150 ml/kg/day (16), translating into 
approximately 900 and 750 μg AAs/day, 
respectively. 
 
The aqueous extracts obtained were filtered 
through 0.45 μm membrane filters prior to 
use as drinking water. Extracts were freshly 
prepared, based on demand, twice a week. 
Six months later all rats were euthanized for 
general autopsy, but particularly studying 
urinary tracts. Kidneys and a liver sample 
were collected and preserved in 4 % formalin 
solution for histology. Tissues were 
embedded in wax blocks and sections (3 μm) 
stained with H & E by the standard hospital 
pathology protocol for reviewing in Romania. 
 
Experiment 2 
 
Six female Sprague-Dawley rats (5 weeks 
old, 100-125 g) were given AAI (purity >97%; 
Sigma-Aldrich Corporation, St. Louis, MO, 
USA) by gavage at a dosage of 50 mg/ kg 
b.w. Approximately 5.5 mg AAI sodium salt 
dissolved in 20% ethanol in phosphate 
buffered saline was administered (1 ml) to 
each rat on three consecutive days. 
Thereafter, animals were maintained on 
standard rat diet for a further seven months 
at an average body weight of 255 g. 
 
Three female Sprague-Dawley rats weighing 
150-170 g were administered AA I in 
solution in a Pliocene lignite aqueous 
extract. This extract was prepared from coal 
samples collected from the Husnicioara 
open pit mine (South-western Romania) in 
September 2011. A Soxhlet method was 
used for extraction, with 10 g of coal and 
250 mL bi-distilled water for 5 days; the 
aqueous extract had a brownish colour and 
was used as a solvent for dissolving the AAI 
(purity >97%, Sigma-Aldrich, St. Louis, MO, 
USA). The gavage solution (1 mL) delivered 
approximately 5.5 mg AAI sodium salt/rat/
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Figure 2.  p-S6 staining in AA treated kidneys. A,   AA I treated kidneys showing staining for p-S6 
protein principally in the papilla, contrasting with Experiment 1; B, detail in papilla (bar 100 μm). 
 
 
day on three consecutive days. Thereafter, 
animals were maintained in standard 
(control) conditions for six months. 
Resource constraints focused all available 
animals in experiment 2 on treated groups; 
general controls were those in experiment 1, 
noting that in (8) 22 control rats had been 
without disease throughout. 
 
Immunohistochemistry for p-S6 protein 
 
The protocol was as previously described 
(10) and included fresh H & E – stained 
adjacent sections for direct comparison with 
those stained immunohistochemically. In 
brief, immunostaining of 3 μm sections was 
with Vectastain Elite ABC kit (PK-6101). In 
addition, avidin/biotin block (Vectastain 
SP-2001) was applied prior to the primary 
antibody (polyclonal phospho-S6 protein 
[Ser240/244, Cell Signalling #2215] in 
1:200 dilution). Sections were developed 
using DAB, counterstained in Gill ІІІ 
haematoxylin, dehydrated and mounted 
with DPX. Immunostained, and standard 
haematoxylin and eosin (H & E)-stained 
sections were scanned (Hamamatsu 
Nanozoomer) and stored on the digital slide 
server (DSS)  in ndpi format for reviewing 
using Digital Images Hub (Slidepath system) 
for online validation and record. 
 
Results 
 
Experiment 1 
 
None of the rats showed any adverse 
reaction to the treatments, no abnormalities 
were evident at necropsy, and no H & E 
histopathology was evident in longitudinal 
sections of kidney (as also for those stained 
in London; Figure 1 A), or in liver (not 
shown). Concerning use for the first time of 
an immunohistochemical probe in AA 
toxicology, a negative control for p-S6 
protein antibodies (secondary antibody only) 
showed no staining (Figure 1 B). Consistent 
features in all control and treated rats were 
that in all kidneys sectioned through the 
papilla that region was not stained (Figure 
1 C), as in the negative control. There was 
no evidence of proliferation of the 
transitional cell layer in the renal pelvis and 
there was also no staining for p-S6 protein 
there. However, controls had variable 
diffuse staining from inner medulla to cortex 
that seemed to be confined to vascular 
elements but this did not involve glomeruli 
(Figure 1D); the reason for this distinction 
is unclear, but in BEN renal atrophy 
glomeruli are generally well preserved. In 
the cortex of the group receiving Soxhlet 
extract of leaves, diffuse staining of p-S6 
was observed. The group receiving hot water 
extract also showed patchy diffuse staining 
for p-S6 protein in cortex and medulla, but 
there was no strong basis for perceiving 
significant differences attributable to either 
treatment. Overall, there was no 
macroscopic or microscopic evidence of 
tumour growth in response to plant 
extracts, and the diffuse staining pattern of 
p-S6 was not markedly different between 
groups. 
 
Experiment 2  
 
Rats given AA I alone were 100-125 g (mean 
120 ± 6.4 g). After one month the mean was 
186 g, reaching 255 g at seven months, all 
conforming to standard growth data (17) 
and showing no persistent reaction to the 
treatment. Blood plasma creatinine 
concentration increased from the puberty 
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Figure 3. Closely matching longitudinal sections through renal papilla stained with haematoxylin and 
eosin (A) or for p-S6 protein (B) correlating stained areas, probably vascular (note erythrocytes), between 
some ducts and tubules. Bar 50 μm. 
 
 
value at the start (0.33 ± 0.06 mg/dL) to 
0.45 ± 0.05 mg/dL a month later and was 
sustained at 7 months (0.44 ± 0.06 mg/dL).  
Plasma urea was 30 ± 11 mg/dL at the start, 
28 ± 10 mg/dL after one month and 33 ± 10 
mg/dL at 7 months, not significantly 
different. Both hepatic enzymes declined 
slightly in concentration over the period, but 
values remained within normal range. 
Animals also given Pliocene lignite infusion 
as gavage were initially 150-170 g (mean 
164 g). At term, six months later, their mean 
weight was 240 g, similarly typical for this 
breed. Over the treatment period plasma 
creatinine (0.45 ± 0.02 and 0.47 ± 0.06 
mg/dL) and urea (32 ± 8 and 25 ± 3 mg/dL) 
values were maintained, AST was 
unchanged and ALT decreased only slightly, 
though within the normal rat range. As in 
experiment 1, no significant 
histopathological change was evident in 
initial H & E sections. In both experiments, 
ureters and bladders were viewed at 
necropsy for gross change; none was found 
and so tissues were not embedded for 
histology. 
 
Across the two parts of the semi-acute AA I 
experiment, immunological distribution of 
p-S6 protein in kidneys contrasted with that 
in the chronic plant extract experiment 1. 
There was extensive interstitial staining in 
the papilla (Figure 2 A, B), sometimes more 
clearly defined where the preparation was 
slightly oblique to the central sagittal plane, 
showing tubules more in transverse section. 
However, elsewhere staining could be 
matched in H & E preparation (Figure 3A) 
with that of p-S6 to amorphous matrix 
between tubules (Figure 3 B). Notably also, 
diffuse weak staining occurred in cortex, 
usually emphasising the glomeruli, and 
contrasting with absence in the medulla (as 
in Figure  1). There was consistent absence 
of cellular and nuclear proliferation in the 
transitional cell layer lining the renal pelvis, 
and of staining for p-S6 protein.   
Distribution of apparent p-S6 protein over-
expression in response to AA I did not differ 
with inclusion of Pliocene lignite infusion in 
the gavage dosing vehicle.  
 
Immunohistochemistry was crucial for 
recognising a few specific features 
attributed to renal tumourigenesis. Paucity 
of p-S6 protein staining in the outer stripe 
of the outer medulla (OSOM) of one rat in 
the AA I only treatment group, in which 
papilla staining is illustrated in Figures 2 
and 3, enabled observation of a small 
proximal tubule element with intense 
staining for p-S6 protein (Figure 4); 
positional matching to an adjacent section 
stained by H&E revealed a focus of prolifer-
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Figure 4. Seven months after oral gavage with AA.  Adjacent sections in renal outer stripe of the outer 
medulla stained with haematoxylin and eosin (A), or immunohistochemically for expression of p-S6 
protein (B). Stained nephron fragment(s) are interpreted as indicative of a pre-neoplastic lesion (bar 50 
μm). 
 
 
ation (Figure 4A). That staining revealed the 
epithelium of this proximal (straight 
segment) tubule containing a higher 
concentration of cells than in adjacent 
tubules; the cells were crowded, appearing 
hyperplasic or proliferating. A few nuclei 
were slightly larger than others 
(karyomegaly) and all of them contain 
nucleoli. Compared to the other tubules in 
the region, which had nuclei spaced far 
apart, there was a tendency in the particular 
tubule fragment to lose polarity, to initiate a 
sort of stratification. Less prominent, the 
cytoplasm in the cells that had enlarged 
nuclei seemed to have lost some 
eosinophilia to become clearer. Brush 
borders also seemed to be deficient. 
Ribosomal p-S6 protein staining in the 
tubule centre is intense and diffuse within 
the cytoplasm, as was also the edge of 
another nearby tubule fragment, possibly of 
the same tubule (Figure 4B). Other 
proximal tubules in the region either had no 
staining or showed just a weak, apically-
concentrated fine granular reaction. 
 
Discussion 
 
In spite of six months of exposure to AAs in 
drinking water there was no detectable 
adverse clinical or histopathological effect. 
The mild, diffuse over-expression of 
ribosomal p-S6 protein in renal cortex of 
controls seems to be at least partly an 
inconsequential feature of the local water 
supply or of commercial rat diet, which had 
not been evident in previous UK studies in 
London (10). However, the A. clematitis 
infusions, prepared in distilled water, did 
not significantly affect the intensity of 
immunohistochemical staining. Notably, the 
cumulative intake of AA (~1.8 g/kg b.w.) was 
three-fold higher than that given during half 
the exposure period (18) and which had 
caused extensive histopathological changes. 
Therefore, the present pilot study suggests 
that, for environmental toxins, it is futile to 
rely on convenient once-daily gavage or 
parenteral injection for other than 
pharmacokinetic studies, because 
environmental AA seems to be rather well- 
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tolerated in rats if given slowly throughout 
each day. Humans may be similar. In 
contemplating what might be necessary for 
A. clematitis to cause BEN and its tumours, 
the amount may exceed any realistic human 
exposure.  
 
The semi-acute high-insult administration 
of AA I was adopted partly to mimic the end-
point outcome as described previously (8). 
Cui et al. (8) had used AA I (> 95 % purity) 
isolated from Aristolochia manshuriensis 
Kom, presumably not different from the 
commercial AA I used here although there is 
recent concern (19) that highly mutagenic 
AA analogues remain to be recognised in 
some species. Of the 14 rats used, 4 
developed unilateral kidney tumours, and 
the remaining animals showed pre-
neoplastic renal lesions.  Lesions were small 
nodules, the smallest of which were already 
2-3 mm in diameter, while larger ones 
sometimes extended through the renal 
capsule. We were unable to reproduce these 
results, despite prolonging the experiments 
for seven months instead of six. Clearly, our 
present concept of a pre-neoplastic lesion is 
very different (see below).  
 
Interesting comparison can be found in the 
study of Schmeiser et al. (18) which used 
Wistar males, gavaged daily at 10 mg AA 
І/kg b.w., sodium salt in water for 3 months. 
The experiment terminated 7 months after 
starting, as in our present experiment.  
Among 18 treated rats, most gave squamous 
cell carcinomas in the forestomach and 
sometimes also in an ear duct. Other 
tumours occurred in the small intestine and 
/or the pancreas. One occurred in a kidney 
(not studied). Although the treatment had 
been widely carcinogenic there were no 
transitional cell tumours. Similarly, even 
Ivic (2) who first perceived a role for AA in 
the kidney atrophy of BEN, did not find 
experimental urothelial tumours. The 
cumulative dose in (18) had been at least 
that in experiment 2 here, although gavaged 
5 days/week over a much longer period. 
Clearly there is need for experiments on 
short and long-term exposure to AA at a 
range of moderate doses, preferably given in 
feed (20) and based on US National 
Toxicology Programme-like rigour (21), to 
establish the plausible risk of renal cancer 
particularly in transitional cells of the 
kidney pelvis.  
Although we did not observe renal tumours 
or lesions, we observed features of pre-
neoplastic transition in response to AA in 
some areas of the kidney. There was a close 
match between p-S6 staining and 
morphological change as observed by H & E 
staining.  The principal value of 
immunohistochemical staining for p-S6 
protein hyper-expression has been the 
highlighting, for the first time, of a small 
proliferation in the epithelium of proximal 
straight tubule segments of nephron located 
in the OSOM, revealing and matching what 
had not been recognised otherwise in a 
closely-adjacent conventionally stained 
section. This histopathological change 
represents our concept of a pre-neoplastic 
proliferation and is reminiscent of the 
periphery of a matching small neoplastic 
lesion in a rat given protracted exposure to 
dietary OTA (Figure 2A in 10). Our concept 
is also consistent with a literature 
illustration (22). This lesion did not appear 
to be resolving seven months after the AA 
insult and thus could have been a sufficient 
focus for subsequent proliferation towards 
kidney cancer.  
 
Extensive serial sectioning and 
immunohistochemical staining might have 
been expected to reveal other examples, if 
resources had been available. The utility of 
p-S6 as a marker of pre-neoplastic renal 
tubular lesions warrants further 
investigation, but the important feature of 
the present findings is that of AA-initiated 
potential carcinoma arising in renal 
parenchyma, as is the case with another 
nephrotoxin OTA, but not by proliferation in 
the transitional cell epithelium of the renal 
pelvis. To demonstrate the latter 
experimentally as evidence for AA causing 
the urological tumours in BEN patients is 
epidemiologically-desirable to satisfy 
classical (23) and modern (24, 25) criteria. 
Currently, human AA exposure evidence for 
BEN is conflicted (15, 26, 27) and claims 
that AA is the disease determinant (28-30) 
appear premature. 
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